Clinical Trials Directory

Trials / Completed

CompletedNCT01068158

A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects

A Double-Blind Randomized Study to Compare the Efficacy, Safety, and Local Tolerability of a 0.5% Ivermectin Cream Compared to a Topical Vehicle Control in Subjects With Pediculus Humanus Capitis Infestation

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
371 (actual)
Sponsor
Topaz Pharmaceuticals Inc · Industry
Sex
All
Age
5 Months
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if 0.5% Ivermectin Cream is a safe and effective treatment for head lice infestations.

Conditions

Interventions

TypeNameDescription
DRUG0.5% Ivermectin CreamUp to 4 ounces of 0.5% Ivermectin Cream applied to hair and scalp on day 1.
DRUGPlacebo controlup to 4 ounces of topical vehicle control to head and scalp on day 1.

Timeline

Start date
2010-03-01
Primary completion
2010-06-01
Completion
2010-07-01
First posted
2010-02-12
Last updated
2012-04-06
Results posted
2012-04-04

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01068158. Inclusion in this directory is not an endorsement.